Tadalafil in the management of lower urinary tract symptoms: a review of the literature and current practices in Russia

Journal Title: Central European Journal of Urology - Year 2014, Vol 67, Issue 2

Abstract

Introduction Strong epidemiologic evidence supports correlation between lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH) and erectile dysfunction (ED). The link has biologic plausibility given phosphodiesterase type 5 (PDE5) expression in pelvic structures. PDE5 inhibitors target pathophysiologic processes implicated in LUTS/BPH. Material and methods This review highlights the efficacy and safety of the daily use of a PDE5 inhibitor tadalafil in LUTS/BPH, with a focus on LUTS/BPH medical management in Russia. Results Alpha–blockers and phytotherapy are major components of the current LUTS/BPH therapy in Russia. Russian regulatory authorities granted approval for once–daily tadalafil for treatment of LUTS/ BPH in January 2012. In a pivotal study, tadalafil 5 mg once–daily significantly improved International Prostate Symptom Score (IPSS) over 12 weeks vs. placebo (P = .004) regardless of baseline ED severity. IPSS improvement was maintained at 12 weeks. Integrated analysis of randomized studies showed that tadalafil 5 mg once–daily resulted in significant symptom improvements across a range of men with LUTS/BPH. Relief of LUTS due to tadalafil was independent of improvement in ED; improvements in IPSS and erectile function were only weakly correlated (r = –0.229). Another pooled analysis found similar improvement in LUTS/BPH between men with or without ED, with non–significant P values for treatment–by–ED–status interactions for total IPSS ( P = .73). Non–registration studies of tadalafil and alpha–blocker co–therapy in LUTS/BPH suggest an additive effect, but co–therapy is not recommended in current tadalafil prescribing instructions. Conclusions Tadalafil results in symptom improvements across a range of men with LUTS/BPH and represents a new treatment option for patients in Russia with LUTS/BPH.

Authors and Affiliations

Alexander Govorov, George Kasyan, Diana Priymak, Sebastian Sorsaburu

Keywords

Related Articles

Helicobacter pylori: a sexually transmitted bacterium?

Introduction Oral sex (fellatio) is a very common sexual activity. H. pylori is mainly a gastric organism, but studies have reported that infected individuals may permanently or transiently carry H. pylori in their mouth...

Diagnostic significance of biopsies in renal masses

Introduction We investigated the reliability and mapping of percutaneous needle core biopsies in the kidney in histopathological diagnosis of renal masses particularly for those with suspicious radiologic appearance in a...

The influence of direct mobile phone radiation on sperm quality

Introduction It is impossible to imagine a modern socially–active man who does not use mobile devices and/or computers with Wi–Fi function. The effect of mobile phone radiation on male fertility is the subject of recent...

A new corporoplasty based on stratified structure of tunica albuginea for the treatment of congenital penile curvature – long–term results

Introduction The aim of the study was to report long–term results of treatment of patients with conge- nital penile curvature (CPC) with a new corporoplasty based on stratified structure of tunica albuginea, in which co...

Download PDF file
  • EP ID EP340871
  • DOI 10.5173/ceju.2014.02.art10
  • Views 74
  • Downloads 0

How To Cite

Alexander Govorov, George Kasyan, Diana Priymak, Sebastian Sorsaburu (2014). Tadalafil in the management of lower urinary tract symptoms: a review of the literature and current practices in Russia. Central European Journal of Urology, 67(2), 167-176. https://europub.co.uk/articles/-A-340871